Bionet

Taipei, Taiwan Founded: 1999 • Age: 27 yrs
Cord blood banking service provider along with services on genetic testing
Annual revenue - Latest available
Total funding - 1 rounds
Employees - Tracked headcount
Investors 1 Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About Bionet

Bionet is a company based in Taipei (Taiwan) founded in 1999. Bionet operates in a competitive market with competitors including GenVault Corporation, iSpecimen, Indivumed, ViaCell and BioStorage Technologies, among others.

  • Headquarter Taipei, Taiwan
  • Stage Public
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Bionet Corp.
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $1.22 B
    8.4
    as on Dec 31, 2024
  • Net Profit
    $83.7 M
    6.76
    as on Dec 31, 2024
  • EBITDA
    $107.95 M
    -13.15
    as on Dec 31, 2024
  • Latest Funding Round
    $2.86 M (USD), Post-IPO

    Mar 06, 2009

  • Investors
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Bionet

Bionet is a publicly listed company on the TPEX with ticker symbol 1784 in Taiwan, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: TPEX · Ticker: 1784 · Sector: Health technology · Taiwan

Funding Insights of Bionet

Investors in Bionet

Bionet has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Foxconn Electronics.

All
Institutional
Investor Description Founded Year Domain Location
Electronic products and components are manufactured globally by Foxconn.
Locked Locked Locked
Premium access

Investor details for Bionet

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Bionet

Investments
Premium access

Investment portfolio details for Bionet

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Bionet

Premium access

Detailed financials for Bionet

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Bionet Comparisons

Bionet Primary company
Description
Cord blood banking service provider along with services on g...
Location
Taipei, Taiwan
Founded Year
1999
Annual Revenue
$1.22 B
Net Profit
$83.7 M
EBITDA
$107.95 M
Employees
Not available
Premium access

Peer comparison for Bionet

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Bionet

Bionet operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GenVault Corporation, iSpecimen, Indivumed, ViaCell and BioStorage Technologies, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Biosamples are stabilized, transported, stored, and retrieved by GenVault.
Locked Locked Locked
Provider of a biorepository of human clinical specimens
Locked Locked Locked
Biospecimens are collected, preserved, and analyzed for oncology services.
Locked Locked Locked
Provider of services for collecting and preserving umbilical cord blood stem cells
Locked Locked Locked
Provides bio repository services
Locked Locked Locked
A blockchain-based platform for tokenizing and incentivizing stem cell donations
Premium access

Detailed competitors of Bionet

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Bionet

Premium access

Complete news archive for Bionet

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bionet

Bionet was founded in 1999 and raised its 1st funding round 10 years after it was founded.

Bionet is headquartered in Taipei, Taiwan.

Bionet was founded in 1999 in Taipei, Taiwan, within the biotechnology sector. Cord blood banking services are offered alongside genetic testing. Operations extend to stem cell therapeutic applications, including peripheral blood and mesenchymal stem cells such as dental pulp stem cells. Cosmetic therapeutic applications using stem cells are under development. The company focuses on these areas for medical and research purposes.

Bionet's top competitors include iSpecimen, AminoChain and GenVault Corporation.

Yes, Bionet is publicly traded on TPEX under the ticker symbol 1784.

Bionet has 1 investor. Key investors include Foxconn Electronics.

The ticker symbol of Bionet is 1784 on TPEX.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available